Endometrial cancer with progestagen and oestrogen oral contraceptives

The Collaborative Group's meta-analysis of 36 epidemiological studies published from 1987 to 2014 claims that oral contraceptives prevent endometrial cancer.1 The median age of 27 276 women developing endometrial cancer was 63 years when most oral contraceptive use is long past but recent use o...

Full description

Saved in:
Bibliographic Details
Published in:The lancet oncology 2015-11, Vol.16 (15), p.e527-e527
Main Author: Grant, Ellen C G
Format: Article
Language:English
Subjects:
Birth control
Breast cancer
Contraceptives, Oral - adverse effects
Endometrial cancer
Endometrial Neoplasms - epidemiology
Estrogens - adverse effects
Female
Health risk assessment
Hematology, Oncology and Palliative Medicine
Humans
Progestins - adverse effects
Womens health
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Collaborative Group's meta-analysis of 36 epidemiological studies published from 1987 to 2014 claims that oral contraceptives prevent endometrial cancer.1 The median age of 27 276 women developing endometrial cancer was 63 years when most oral contraceptive use is long past but recent use of hormones for menopause or breast cancer therapy is more likely.
ISSN:1470-2045
1474-5488
DOI:10.1016/S1470-2045(15)00278-8